Logo image
IRO Home Research units Researcher Profiles
Sign in
TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer
Journal article   Open access   Peer reviewed

TSPYL Family Regulates CYP17A1 and CYP3A4 Expression: Potential Mechanism Contributing to Abiraterone Response in Metastatic Castration-Resistant Prostate Cancer

Sisi Qin, Duan Liu, Manish Kohli, Liguo Wang, Peter T Vedell, David W Hillman, Nifang Niu, Jia Yu, Richard M Weinshilboum and Liewei Wang
Clinical pharmacology and therapeutics, Vol.104(1), pp.201-210
07/2018
DOI: 10.1002/cpt.907
PMCID: PMC5899062
PMID: 29027195
url
https://doi.org/10.1002/cpt.907View
Published (Version of record) Open Access

Abstract

Abiraterone Acetate - pharmacology Abiraterone Acetate - therapeutic use Cell Cycle Proteins - drug effects Cell Cycle Proteins - genetics Cell Proliferation - drug effects Cell Proliferation - genetics Cytochrome P-450 CYP3A - drug effects Cytochrome P-450 CYP3A - genetics Cytochrome P-450 CYP3A - metabolism Cytochrome P-450 Enzyme Inhibitors - pharmacology Cytochrome P-450 Enzyme Inhibitors - therapeutic use Dehydroepiandrosterone - metabolism Gene Expression Regulation - drug effects Gene Knockdown Techniques Hep G2 Cells Humans Male Neoplasm Metastasis Nuclear Proteins - drug effects Nuclear Proteins - genetics Proportional Hazards Models Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - pathology RNA, Messenger - metabolism Steroid 17-alpha-Hydroxylase - antagonists & inhibitors Steroid 17-alpha-Hydroxylase - drug effects Steroid 17-alpha-Hydroxylase - genetics Treatment Outcome

Details

Metrics

Logo image